Enhanced extracorporeal elimination of valproic acid in overdose

Netherlands Journal of Medicine

Volumn 62, Issue 9, 2004, Pages 307-308

  Engbersen, R ^a   Kramers, C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; ANTIDOTE; DIGOXIN; ETHYLENE GLYCOL; FIBRINOGEN; PARACETAMOL; SALICYLIC ACID DERIVATIVE; THEOPHYLLINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID;

ALKALINIZATION; DISEASE SEVERITY; DIURESIS; DRUG ABSORPTION; DRUG BINDING; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG INTOXICATION; DRUG OVERDOSE; EDITORIAL; EVIDENCE BASED MEDICINE; EXTRACORPOREAL CIRCULATION; HEMODIALYSIS; HEMOFILTRATION; HEMOLYSIS; HEMOPERFUSION; HUMAN; MEDICAL DECISION MAKING; OUTCOMES RESEARCH; PROTEIN BINDING; STOMACH LAVAGE; THROMBOCYTOPENIA; URINE PH;

GASTRIC LAVAGE; HEMOFILTRATION; HEMOPERFUSION; HUMANS; OVERDOSE; VALPROIC ACID;

EID: 6444236493     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (10)

1. Garella S. Extracorporeal techniques in the treatment of exogenous intoxications. Kidney Int 1988;33:735-54.
2. Sztajnkrycer MD. Valproic acid toxicity: overview and management. J Toxicol Clin Toxicol 2002;40:789-801.
3. Ingels M, Beauchamp J, Clark RF, Williams SR. Delayed valproic acid toxicity: a retrospective case series. Ann Emerg Med 2002;39:616-21.
4. Chadwick DW. Concentration-effect relationships of valproic acid. Clin Pharmacokinet 1985;10:155-63.
5. Gwilt PR, Perrier D. Plasma protein binding and distribution characteristics of drugs as indices of their haemodialyzability. Clin Pharmacol Ther 1978;24:154-61.
6. Zaccara G, Messori A, Moroni F. Cliniul pharmacokinetics of valproic acid - 1988. Clin Pharmacokinet 1988;15:367-89.
7. Meek MF, Broekroelofs J, Yska JP, Egbers PHM, Boerma EC, Voort PHJ van der. Valproic acid intoxication: sense and non-sense of hemodialysis. Neth J Med 2004;62:333-36.
8. Marbury TC, Lee CS, Bruni J, Wilder BJ. Haemodialysis of valproic acid in uremic patients. Dial Transplant 1980;9:961-4.
9. Bowdle AT, Patel IH, Levy RH, Wilensky AJ. Valproic acid dosage and plasma protein binding and clearance. Clin Pharmacol Ther 1980;28:486-92.
10. Golper TA, Bennett WM. Drug removal by continuous arteriovenous haemofiltration. A review of the evidence in poisoned patients. Med Toxicol Adverse Drug Exp 1988;3:341-9.